2023-03-22 18:10:00 ET
McKesson (NYSE: MCK) , a healthcare supplier that was founded in 1833, is a value investor's dream. It has a relatively low valuation and strong long-term growth potential. Over the past three years, it also has delivered a total return of 485.64%.
The company has seen its shares rise more than 15% over the past year, though they have fallen more than 7% so far in 2023. McKesson recently raised its guidance for fiscal 2023, citing operational momentum.
The company's dividend isn't particularly generous, but its dependable revenue and net-income growth make it stand out. Considering the stock's sluggishness to start the year, does it still make sense to buy McKesson stock? Let's see.
For further details see:
Is It Too Late to Buy McKesson Stock?